DT120

Advertisement

cGxPJobs Banner

Definium Therapeutics to Present Phase 3 DT120 Data at Psych Congress

NEW YORK — September 10, 2026 Definium Therapeutics, Inc. announced plans to present six posters and an invited oral...

By cGxPwire Editor
September 12, 2026

Read More

Definium Therapeutics Gains FDA Breakthrough Therapy Designation for DT120 in MDD

NEW YORK — September 8, 2026 Definium Therapeutics announced that the U.S. Food and Drug Administration (FDA) has granted...

By cGxPwire Editor
September 9, 2026

Read More

Advertisement

cGxPJobs

Directory